 | • レポートコード：MRC308GR11342 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の成人悪性神経膠腫治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の成人悪性神経膠腫治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 成人悪性神経膠腫治療の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
成人悪性神経膠腫治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・化学療法、標的薬物療法
用途別セグメント
・多形膠芽腫、退形成性星細胞腫、退形成性乏突起膠腫、退形成性乏突起星細胞腫、その他
主要な市場プレーヤー
・Merck & Co., Inc、F. Hoffmann-La Roche Ltd、Arbor Pharmaceuticals、Pfizer,Inc、AbbVie, Inc、Amgen, Inc、Bristol-Myers Squibb Company、Sun Pharmaceuticals Ltd、Teva Pharmaceutical Industries Limited、Emcure Pharmaceuticals Limited、Bayer、SL Pharm、Boan Biotech
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、成人悪性神経膠腫治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な成人悪性神経膠腫治療メーカーの企業概要、2019年～2022年までの成人悪性神経膠腫治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な成人悪性神経膠腫治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別成人悪性神経膠腫治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの成人悪性神経膠腫治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での成人悪性神経膠腫治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および成人悪性神経膠腫治療の産業チェーンを掲載しています。
・第14、15章では、成人悪性神経膠腫治療の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 成人悪性神経膠腫治療の概要
– 種類別分析（2018年vs2022年vs2029年）：化学療法、標的薬物療法
– 用途別分析（2018年vs2022年vs2029年）：多形膠芽腫、退形成性星細胞腫、退形成性乏突起膠腫、退形成性乏突起星細胞腫、その他
– 世界の成人悪性神経膠腫治療市場規模・予測
– 世界の成人悪性神経膠腫治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck & Co., Inc、F. Hoffmann-La Roche Ltd、Arbor Pharmaceuticals、Pfizer,Inc、AbbVie, Inc、Amgen, Inc、Bristol-Myers Squibb Company、Sun Pharmaceuticals Ltd、Teva Pharmaceutical Industries Limited、Emcure Pharmaceuticals Limited、Bayer、SL Pharm、Boan Biotech
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：化学療法、標的薬物療法
・用途別分析2018年-2029年：多形膠芽腫、退形成性星細胞腫、退形成性乏突起膠腫、退形成性乏突起星細胞腫、その他
・成人悪性神経膠腫治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・成人悪性神経膠腫治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・成人悪性神経膠腫治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・成人悪性神経膠腫治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・成人悪性神経膠腫治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Adult Malignant Glioma Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Adult Malignant Glioma Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Chemotherapy
1.3.3 Targeted Drug Therapy
1.4 Market Analysis by Application
1.4.1 Overview: Global Adult Malignant Glioma Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Glioblastoma Multiforme
1.4.3 Anaplastic Astrocytoma
1.4.4 Anaplastic Oligodendroglioma
1.4.5 Anaplastic Oligoastrocytoma
1.4.6 Other
1.5 Global Adult Malignant Glioma Treatment Market Size & Forecast
1.5.1 Global Adult Malignant Glioma Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Adult Malignant Glioma Treatment Sales Quantity (2018-2029)
1.5.3 Global Adult Malignant Glioma Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck & Co., Inc
2.1.1 Merck & Co., Inc Details
2.1.2 Merck & Co., Inc Major Business
2.1.3 Merck & Co., Inc Adult Malignant Glioma Treatment Product and Services
2.1.4 Merck & Co., Inc Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck & Co., Inc Recent Developments/Updates
2.2 F. Hoffmann-La Roche Ltd
2.2.1 F. Hoffmann-La Roche Ltd Details
2.2.2 F. Hoffmann-La Roche Ltd Major Business
2.2.3 F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Product and Services
2.2.4 F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
2.3 Arbor Pharmaceuticals
2.3.1 Arbor Pharmaceuticals Details
2.3.2 Arbor Pharmaceuticals Major Business
2.3.3 Arbor Pharmaceuticals Adult Malignant Glioma Treatment Product and Services
2.3.4 Arbor Pharmaceuticals Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Arbor Pharmaceuticals Recent Developments/Updates
2.4 Pfizer,Inc
2.4.1 Pfizer,Inc Details
2.4.2 Pfizer,Inc Major Business
2.4.3 Pfizer,Inc Adult Malignant Glioma Treatment Product and Services
2.4.4 Pfizer,Inc Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer,Inc Recent Developments/Updates
2.5 AbbVie, Inc
2.5.1 AbbVie, Inc Details
2.5.2 AbbVie, Inc Major Business
2.5.3 AbbVie, Inc Adult Malignant Glioma Treatment Product and Services
2.5.4 AbbVie, Inc Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AbbVie, Inc Recent Developments/Updates
2.6 Amgen, Inc
2.6.1 Amgen, Inc Details
2.6.2 Amgen, Inc Major Business
2.6.3 Amgen, Inc Adult Malignant Glioma Treatment Product and Services
2.6.4 Amgen, Inc Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amgen, Inc Recent Developments/Updates
2.7 Bristol-Myers Squibb Company
2.7.1 Bristol-Myers Squibb Company Details
2.7.2 Bristol-Myers Squibb Company Major Business
2.7.3 Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Product and Services
2.7.4 Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.8 Sun Pharmaceuticals Ltd
2.8.1 Sun Pharmaceuticals Ltd Details
2.8.2 Sun Pharmaceuticals Ltd Major Business
2.8.3 Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Product and Services
2.8.4 Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sun Pharmaceuticals Ltd Recent Developments/Updates
2.9 Teva Pharmaceutical Industries Limited
2.9.1 Teva Pharmaceutical Industries Limited Details
2.9.2 Teva Pharmaceutical Industries Limited Major Business
2.9.3 Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Product and Services
2.9.4 Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Teva Pharmaceutical Industries Limited Recent Developments/Updates
2.10 Emcure Pharmaceuticals Limited
2.10.1 Emcure Pharmaceuticals Limited Details
2.10.2 Emcure Pharmaceuticals Limited Major Business
2.10.3 Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Product and Services
2.10.4 Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Emcure Pharmaceuticals Limited Recent Developments/Updates
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business
2.11.3 Bayer Adult Malignant Glioma Treatment Product and Services
2.11.4 Bayer Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bayer Recent Developments/Updates
2.12 SL Pharm
2.12.1 SL Pharm Details
2.12.2 SL Pharm Major Business
2.12.3 SL Pharm Adult Malignant Glioma Treatment Product and Services
2.12.4 SL Pharm Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 SL Pharm Recent Developments/Updates
2.13 Boan Biotech
2.13.1 Boan Biotech Details
2.13.2 Boan Biotech Major Business
2.13.3 Boan Biotech Adult Malignant Glioma Treatment Product and Services
2.13.4 Boan Biotech Adult Malignant Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Boan Biotech Recent Developments/Updates
3 Competitive Environment: Adult Malignant Glioma Treatment by Manufacturer
3.1 Global Adult Malignant Glioma Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Adult Malignant Glioma Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Adult Malignant Glioma Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Adult Malignant Glioma Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Adult Malignant Glioma Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Adult Malignant Glioma Treatment Manufacturer Market Share in 2022
3.5 Adult Malignant Glioma Treatment Market: Overall Company Footprint Analysis
3.5.1 Adult Malignant Glioma Treatment Market: Region Footprint
3.5.2 Adult Malignant Glioma Treatment Market: Company Product Type Footprint
3.5.3 Adult Malignant Glioma Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Adult Malignant Glioma Treatment Market Size by Region
4.1.1 Global Adult Malignant Glioma Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Adult Malignant Glioma Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Adult Malignant Glioma Treatment Average Price by Region (2018-2029)
4.2 North America Adult Malignant Glioma Treatment Consumption Value (2018-2029)
4.3 Europe Adult Malignant Glioma Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Adult Malignant Glioma Treatment Consumption Value (2018-2029)
4.5 South America Adult Malignant Glioma Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Adult Malignant Glioma Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2029)
5.2 Global Adult Malignant Glioma Treatment Consumption Value by Type (2018-2029)
5.3 Global Adult Malignant Glioma Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2029)
6.2 Global Adult Malignant Glioma Treatment Consumption Value by Application (2018-2029)
6.3 Global Adult Malignant Glioma Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2029)
7.2 North America Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2029)
7.3 North America Adult Malignant Glioma Treatment Market Size by Country
7.3.1 North America Adult Malignant Glioma Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Adult Malignant Glioma Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Adult Malignant Glioma Treatment Market Size by Country
8.3.1 Europe Adult Malignant Glioma Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Adult Malignant Glioma Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Adult Malignant Glioma Treatment Market Size by Region
9.3.1 Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Adult Malignant Glioma Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2029)
10.2 South America Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2029)
10.3 South America Adult Malignant Glioma Treatment Market Size by Country
10.3.1 South America Adult Malignant Glioma Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Adult Malignant Glioma Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Adult Malignant Glioma Treatment Market Size by Country
11.3.1 Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Adult Malignant Glioma Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Adult Malignant Glioma Treatment Market Drivers
12.2 Adult Malignant Glioma Treatment Market Restraints
12.3 Adult Malignant Glioma Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Adult Malignant Glioma Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Adult Malignant Glioma Treatment
13.3 Adult Malignant Glioma Treatment Production Process
13.4 Adult Malignant Glioma Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Adult Malignant Glioma Treatment Typical Distributors
14.3 Adult Malignant Glioma Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Adult Malignant Glioma Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adult Malignant Glioma Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co., Inc Major Business
Table 5. Merck & Co., Inc Adult Malignant Glioma Treatment Product and Services
Table 6. Merck & Co., Inc Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck & Co., Inc Recent Developments/Updates
Table 8. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 9. F. Hoffmann-La Roche Ltd Major Business
Table 10. F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Product and Services
Table 11. F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 13. Arbor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Arbor Pharmaceuticals Major Business
Table 15. Arbor Pharmaceuticals Adult Malignant Glioma Treatment Product and Services
Table 16. Arbor Pharmaceuticals Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Arbor Pharmaceuticals Recent Developments/Updates
Table 18. Pfizer,Inc Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer,Inc Major Business
Table 20. Pfizer,Inc Adult Malignant Glioma Treatment Product and Services
Table 21. Pfizer,Inc Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer,Inc Recent Developments/Updates
Table 23. AbbVie, Inc Basic Information, Manufacturing Base and Competitors
Table 24. AbbVie, Inc Major Business
Table 25. AbbVie, Inc Adult Malignant Glioma Treatment Product and Services
Table 26. AbbVie, Inc Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AbbVie, Inc Recent Developments/Updates
Table 28. Amgen, Inc Basic Information, Manufacturing Base and Competitors
Table 29. Amgen, Inc Major Business
Table 30. Amgen, Inc Adult Malignant Glioma Treatment Product and Services
Table 31. Amgen, Inc Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Amgen, Inc Recent Developments/Updates
Table 33. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 34. Bristol-Myers Squibb Company Major Business
Table 35. Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Product and Services
Table 36. Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bristol-Myers Squibb Company Recent Developments/Updates
Table 38. Sun Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Sun Pharmaceuticals Ltd Major Business
Table 40. Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Product and Services
Table 41. Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sun Pharmaceuticals Ltd Recent Developments/Updates
Table 43. Teva Pharmaceutical Industries Limited Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceutical Industries Limited Major Business
Table 45. Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Product and Services
Table 46. Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Teva Pharmaceutical Industries Limited Recent Developments/Updates
Table 48. Emcure Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 49. Emcure Pharmaceuticals Limited Major Business
Table 50. Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Product and Services
Table 51. Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Emcure Pharmaceuticals Limited Recent Developments/Updates
Table 53. Bayer Basic Information, Manufacturing Base and Competitors
Table 54. Bayer Major Business
Table 55. Bayer Adult Malignant Glioma Treatment Product and Services
Table 56. Bayer Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Bayer Recent Developments/Updates
Table 58. SL Pharm Basic Information, Manufacturing Base and Competitors
Table 59. SL Pharm Major Business
Table 60. SL Pharm Adult Malignant Glioma Treatment Product and Services
Table 61. SL Pharm Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. SL Pharm Recent Developments/Updates
Table 63. Boan Biotech Basic Information, Manufacturing Base and Competitors
Table 64. Boan Biotech Major Business
Table 65. Boan Biotech Adult Malignant Glioma Treatment Product and Services
Table 66. Boan Biotech Adult Malignant Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Boan Biotech Recent Developments/Updates
Table 68. Global Adult Malignant Glioma Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Adult Malignant Glioma Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Adult Malignant Glioma Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Adult Malignant Glioma Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Adult Malignant Glioma Treatment Production Site of Key Manufacturer
Table 73. Adult Malignant Glioma Treatment Market: Company Product Type Footprint
Table 74. Adult Malignant Glioma Treatment Market: Company Product Application Footprint
Table 75. Adult Malignant Glioma Treatment New Market Entrants and Barriers to Market Entry
Table 76. Adult Malignant Glioma Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Adult Malignant Glioma Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Adult Malignant Glioma Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Adult Malignant Glioma Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Adult Malignant Glioma Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Adult Malignant Glioma Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Adult Malignant Glioma Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Adult Malignant Glioma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Adult Malignant Glioma Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Adult Malignant Glioma Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Adult Malignant Glioma Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Adult Malignant Glioma Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Adult Malignant Glioma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Adult Malignant Glioma Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Adult Malignant Glioma Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Adult Malignant Glioma Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Adult Malignant Glioma Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Adult Malignant Glioma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Adult Malignant Glioma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Adult Malignant Glioma Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Adult Malignant Glioma Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Adult Malignant Glioma Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Adult Malignant Glioma Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Adult Malignant Glioma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Adult Malignant Glioma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Adult Malignant Glioma Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Adult Malignant Glioma Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Adult Malignant Glioma Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Adult Malignant Glioma Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Adult Malignant Glioma Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Adult Malignant Glioma Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Adult Malignant Glioma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Adult Malignant Glioma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Adult Malignant Glioma Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Adult Malignant Glioma Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Adult Malignant Glioma Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Adult Malignant Glioma Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Adult Malignant Glioma Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Adult Malignant Glioma Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Adult Malignant Glioma Treatment Raw Material
Table 136. Key Manufacturers of Adult Malignant Glioma Treatment Raw Materials
Table 137. Adult Malignant Glioma Treatment Typical Distributors
Table 138. Adult Malignant Glioma Treatment Typical Customers
List of Figures
Figure 1. Adult Malignant Glioma Treatment Picture
Figure 2. Global Adult Malignant Glioma Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adult Malignant Glioma Treatment Consumption Value Market Share by Type in 2022
Figure 4. Chemotherapy Examples
Figure 5. Targeted Drug Therapy Examples
Figure 6. Global Adult Malignant Glioma Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Adult Malignant Glioma Treatment Consumption Value Market Share by Application in 2022
Figure 8. Glioblastoma Multiforme Examples
Figure 9. Anaplastic Astrocytoma Examples
Figure 10. Anaplastic Oligodendroglioma Examples
Figure 11. Anaplastic Oligoastrocytoma Examples
Figure 12. Other Examples
Figure 13. Global Adult Malignant Glioma Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Adult Malignant Glioma Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Adult Malignant Glioma Treatment Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Adult Malignant Glioma Treatment Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Adult Malignant Glioma Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Adult Malignant Glioma Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Adult Malignant Glioma Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Adult Malignant Glioma Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Adult Malignant Glioma Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Adult Malignant Glioma Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Adult Malignant Glioma Treatment Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Adult Malignant Glioma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Adult Malignant Glioma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Adult Malignant Glioma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Adult Malignant Glioma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Adult Malignant Glioma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Adult Malignant Glioma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Adult Malignant Glioma Treatment Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Adult Malignant Glioma Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Adult Malignant Glioma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Adult Malignant Glioma Treatment Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Adult Malignant Glioma Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Adult Malignant Glioma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Adult Malignant Glioma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Adult Malignant Glioma Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Adult Malignant Glioma Treatment Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Adult Malignant Glioma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Adult Malignant Glioma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Adult Malignant Glioma Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Adult Malignant Glioma Treatment Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Adult Malignant Glioma Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Adult Malignant Glioma Treatment Consumption Value Market Share by Region (2018-2029)
Figure 55. China Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Adult Malignant Glioma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Adult Malignant Glioma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Adult Malignant Glioma Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Adult Malignant Glioma Treatment Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Adult Malignant Glioma Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Adult Malignant Glioma Treatment Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Adult Malignant Glioma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Adult Malignant Glioma Treatment Market Drivers
Figure 76. Adult Malignant Glioma Treatment Market Restraints
Figure 77. Adult Malignant Glioma Treatment Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Adult Malignant Glioma Treatment in 2022
Figure 80. Manufacturing Process Analysis of Adult Malignant Glioma Treatment
Figure 81. Adult Malignant Glioma Treatment Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source